GlobalData on MSN10h
Lilly’s EBGLYSS shows improvement in Phase IIIb study for atopic dermatitis
The ADapt study assessed the efficacy and safety of EBGLYSS in individuals who had previously been treated with dupilumab.
Positive Buy Rating for Celldex due to Promising Phase 2 Results and Market Potential in CIndU Treatment
Wells Fargo analyst Derek Archila has maintained their bullish stance on CLDX stock, giving a Buy rating yesterday. Derek Archila has given ...
PharmiWeb9h
Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI
Dupixent significantly reduced itch and hive activity from baseline; 41% of patients achieved well-controlled disease statusConfirmatory data to support US regulatory resubmission by year-end; if ...
Outsports on MSN3h
WNBA legend Diana Taurasi on ‘the beauty’ of being LGBTQ and out, ‘amazing’ Brittney Griner, and eczema awareness
October is LGBTQ History Month and Eczema Awareness Month. Outsports Power 100 honoree Diana Taurasi talks about both. The post WNBA legend Diana Taurasi on ‘the beauty’ of being LGBTQ and out, ...
Dental Implants Market Size to Reach $11.28 Billion By 2031 | CAGR 8.3%: The Insight Partners
According to a new comprehensive report from The Insight Partners, the Global Dental Implants Market is observing significant ...
Greek Reporter22h
Greek News
The Parthenon Sculptures will be returned to Greece, Nikolaos Stambolidis, the general director of the Acropolis Museum, told Greece's public broadcaster ERT. In a recent statement, Stambolidis ...